81 – 90 of 258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.
Alkner, Sara LU ; Bendahl, Po ; Grabau, Dorthe LU ; Malmström, Per LU ; Fernö, Mårten LU and Rydén, Lisa LU
(2013)
In Annals of Oncology
24(5).
p.1244-1252
- Contribution to journal › Article
-
Mark
A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial.
- Contribution to journal › Article
-
Mark
Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution.
Grabau, Dorthe LU ; Dihge, Looket LU ; Fernö, Mårten LU ; Ingvar, Christian LU and Rydén, Lisa LU
(2013)
In European Journal of Surgical Oncology
39(6).
p.601-607
- Contribution to journal › Article
-
Mark
G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
Broselid, Stefan LU ; Cheng, Benxu ; Sjöström, Martin LU ; Lövgren, Kristina LU ; Klug-De Santiago, Heather L P ; Belting, Mattias LU ; Jirström, Karin LU
; Malmström, Per
LU
; Olde, Björn
LU
and Bendahl, Pär-Ola
LU
, et al.
(2013)
In Clinical Cancer Research
19(7).
p.1681-1692
- Contribution to journal › Article
-
Mark
St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial
Falck, Anna-Karin LU ; Fernö, Mårten LU ; Bendahl, Pär-Ola LU and Rydén, Lisa LU
(2013)
In BMC Cancer
13.
- Contribution to journal › Article
-
Mark
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
Forsare, Carina LU
; Bak, Martin
; Borgquist, Signe
LU
; Chebil, Gunilla
; Falck, Anna-Karin
LU
; Fjällskog, Marie-Louise
; Grabau, Dorthe
LU
; Hedenfalk, Ingrid
LU
; Jirström, Karin
LU
and Klintman, Marie
LU
, et al.
(2013)
In SpringerPlus
2(1).
- Contribution to journal › Article
-
Mark
Increased expression of insulin-like growth factor-1 receptor is associated with better prognosis in a cohort of tamoxifen treated women
Aaltonen, Kristina LU
; Olsson, H.
; Rosendahl, Ann
LU
; Malmström, Per
LU
; Hartman, L
and Fernö, Mårten
LU
(2013)
In Cancer Research
73(24 Supplement).
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study
Falck, Anna-Karin LU ; Bendahl, Pär-Ola LU ; Ingvar, Christian LU ; Isola, Jorma LU ; Jönsson, Per-Ebbe LU ; Lindblom, Pia LU ; Lövgren, Kristina LU ; Rennstam, Karin LU ; Fernö, Mårten LU and Rydén, Lisa LU
(2012)
In BMC Cancer
12.
- Contribution to journal › Article
-
Mark
Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer.
Forsare, Carina LU
; Ahlin, Cecilia
; Bendahl, Pär-Ola
LU
; Fjällskog, Marie-Louise
; Hedenfalk, Ingrid
LU
; Malmström, Per
LU
and Fernö, Mårten
LU
(2012)
In Breast Cancer Research and Treatment
131.
p.33-40
- Contribution to journal › Article
-
Mark
Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial
- Contribution to journal › Article